Totally Past Earnings Performance
Past criteria checks 0/6
Totally has been growing earnings at an average annual rate of 8.1%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 2% per year.
Key information
8.1%
Earnings growth rate
23.2%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 2.0% |
| Return on equity | -3.7% |
| Net Margin | -1.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Totally plc's (LON:TLY) Share Price Boosted 48% But Its Business Prospects Need A Lift Too
Aug 02
Is Totally (LON:TLY) Using Debt In A Risky Way?
Jul 26Totally plc (LON:TLY) Stock Catapults 65% Though Its Price And Business Still Lag The Industry
May 08Totally plc's (LON:TLY) Shares Bounce 54% But Its Business Still Trails The Industry
Feb 17These 4 Measures Indicate That Totally (LON:TLY) Is Using Debt Extensively
Feb 06Estimating The Intrinsic Value Of Totally plc (LON:TLY)
Sep 02Is Totally (LON:TLY) A Risky Investment?
Jul 11Is There An Opportunity With Totally plc's (LON:TLY) 45% Undervaluation?
Apr 20Is Totally plc (LON:TLY) Potentially Undervalued?
Sep 06Totally's (LON:TLY) Promising Earnings May Rest On Soft Foundations
Nov 22At UK£0.36, Is It Time To Put Totally plc (LON:TLY) On Your Watch List?
Nov 17Shareholders Will Probably Hold Off On Increasing Totally plc's (LON:TLY) CEO Compensation For The Time Being
Aug 31An Intrinsic Calculation For Totally plc (LON:TLY) Suggests It's 50% Undervalued
Jul 16How Much Is Totally plc (LON:TLY) CEO Getting Paid?
Feb 03Does Totally's (LON:TLY) Share Price Gain of 63% Match Its Business Performance?
Dec 08Revenue & Expenses Breakdown
How Totally makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 93 | -1 | 13 | 0 |
| 30 Jun 24 | 100 | -2 | 15 | 0 |
| 31 Mar 24 | 107 | -3 | 16 | 0 |
| 31 Dec 23 | 114 | -2 | 17 | 0 |
| 30 Sep 23 | 121 | -1 | 18 | 0 |
| 30 Jun 23 | 128 | 0 | 18 | 0 |
| 31 Mar 23 | 136 | 2 | 18 | 0 |
| 31 Dec 22 | 136 | 1 | 18 | 0 |
| 30 Sep 22 | 136 | 1 | 17 | 0 |
| 30 Jun 22 | 132 | 1 | 17 | 0 |
| 31 Mar 22 | 127 | 1 | 17 | 0 |
| 31 Dec 21 | 124 | 1 | 17 | 0 |
| 30 Sep 21 | 121 | 1 | 17 | 0 |
| 30 Jun 21 | 117 | 1 | 17 | 0 |
| 31 Mar 21 | 114 | 0 | 16 | 0 |
| 31 Dec 20 | 112 | 0 | 16 | 0 |
| 30 Sep 20 | 111 | 0 | 15 | 0 |
| 30 Jun 20 | 108 | -2 | 15 | 0 |
| 31 Mar 20 | 106 | -3 | 15 | 0 |
| 31 Dec 19 | 97 | -3 | 14 | 0 |
| 30 Sep 19 | 87 | -3 | 13 | 0 |
| 30 Jun 19 | 83 | -2 | 12 | 0 |
| 31 Mar 19 | 78 | -2 | 11 | 0 |
| 30 Sep 18 | 71 | 2 | 9 | 0 |
| 30 Jun 18 | 52 | 2 | 7 | 0 |
| 31 Mar 18 | 34 | 1 | 5 | 0 |
| 31 Dec 17 | 21 | -2 | 6 | 0 |
| 30 Sep 17 | 14 | -2 | 5 | 0 |
| 30 Jun 17 | 7 | -2 | 4 | 0 |
| 31 Mar 17 | 5 | -2 | 3 | 0 |
| 31 Dec 16 | 4 | -2 | 3 | 0 |
| 30 Sep 16 | 3 | -1 | 2 | 0 |
| 30 Jun 16 | 1 | -1 | 1 | 0 |
| 31 Mar 16 | 1 | -1 | 1 | 0 |
| 31 Dec 15 | 1 | 0 | 1 | 0 |
| 30 Sep 15 | 1 | 0 | 1 | 0 |
| 30 Jun 15 | 1 | 0 | 1 | 0 |
| 31 Mar 15 | 1 | 0 | 1 | 0 |
| 31 Dec 14 | 1 | 0 | 1 | 0 |
| 30 Jun 14 | 0 | -1 | 1 | 0 |
| 31 Mar 14 | 1 | -1 | 1 | 0 |
| 31 Dec 13 | 1 | -1 | 1 | 0 |
Quality Earnings: TLY is currently unprofitable.
Growing Profit Margin: TLY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TLY is unprofitable, but has reduced losses over the past 5 years at a rate of 8.1% per year.
Accelerating Growth: Unable to compare TLY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TLY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.2%).
Return on Equity
High ROE: TLY has a negative Return on Equity (-3.74%), as it is currently unprofitable.